News

Adoption and cost-effectiveness of IPF therapies
Fibrotic remodelling occurs in many diseases. Thinking about idiopathic pulmonary fibrosis (IPF) as a ‘purely’ fibrotic condition, with currently unknown aetiology, may offer strategic insights

Happy Birthday TherapeutAix! Celebrating our third year
As TherapeutAix celebrates our three-year birthday this month, we thought it would be a great opportunity to take a look back at our achievements over

Reflections from ERS
Having joined a wide range of sessions at the virtual ERS meeting last week, we were keen to share some of our reflections. Despite the virtual format

Working in Respiratory Diseases – Our Capabilities
As this year’s ERS meeting is about to kick off, we’ve looked back at the last three years at TherapeutAix and the 20 projects we

Collaboration and Outsourcing in Drug Discovery – Presentation
Last month, we had the pleasure of hosting the “Collaboration and Outsourcing in Drug Discovery” Workshop at this year’s Bio2Business BOS Virtual event. The workshop

TherapeutAix to host Outsourcing Workshop at BOS Virtual 2021
Darcey Black and Simon Cruwys will be running the Outsourcing Workshop at this year’s BOS Virtual. Biotech Outsourcing Strategies is an established outsourcing focused conference and exhibition

NASH – Challenges for drug development
It’s International NASH Day – and it’s also a while since we have last discussed NASH on the blog. In fact, even more has changed